California State Teachers Retirement System (CalSTRS)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-22,327
Closed -$126K 3157
2016
Q1
$126K Buy
22,327
+3,362
+18% +$43.7K ﹤0.01% 2890
2015
Q4
$326K Buy
18,965
+337
+2% +$8.04K ﹤0.01% 2672
2015
Q3
$393K Sell
18,628
-60
-0.3% -$2.06K ﹤0.01% 2584
2015
Q2
$925K Sell
18,688
-3,725
-17% -$223K ﹤0.01% 2157
2015
Q1
$1.75M Sell
22,413
-330
-1% -$20.5K ﹤0.01% 1699
2014
Q4
$1.38M Buy
22,743
+97
+0.4% +$4.87K ﹤0.01% 1838
2014
Q3
$965K Buy
22,646
+1,411
+7% +$75.8K ﹤0.01% 2024
2014
Q2
$1.31M Buy
21,235
+940
+5% +$54.7K ﹤0.01% 1881
2014
Q1
$1.32M Buy
20,295
+1,940
+11% +$131K ﹤0.01% 1815
2013
Q4
$1.03M Buy
18,355
+1,320
+8% +$74.2K ﹤0.01% 1973
2013
Q3
$1.05M Buy
17,035
+543
+3% +$36.8K ﹤0.01% 1906
2013
Q2
$965K Buy
+16,492
New +$1.01M ﹤0.01% 1887

Other funds holding OREX

California State Teachers Retirement System (CalSTRS)'s OREX Position: Q2 2016 in Review

California State Teachers Retirement System (CalSTRS) sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 22,327 shares — an estimated $126K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in OREX in Q2 2013 and held it in 12 quarters. The position peaked at $1.75M in Q1 2015. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 22,327 Orexigen Therapeutics, Inc. shares in Q2 2016, an estimated $126K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Orexigen Therapeutics, Inc. position peaked at $1.75M in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2016, filed 1 Aug 2016.